[Rectal localization of Wegener's disease].
Herody
M
M
Bili
H
H
Duvic
C
C
Coutant
G
G
Camparo
P
P
Nedelec
G
G
Algayres
J P
JP
Daly
J P
JP
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012002:Rectal Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D012128:Respiratory Distress Syndrome / Q000209:etiology*
D018906:Antineoplastic Agents, Alkylating; D005938:Glucocorticoids; D003520:Cyclophosphamide; D011241:Prednisone
Localisation rectale d'une maladie de Wegener.